Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy

The development of multifunctional agents that could be used for simultaneous tumor targeting, imaging and treatment is a major goal in cancer research and is expected to contribute significantly to the realization of personalized oncology. Mitochondria are involved in diverse physiological activiti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug discovery today 2011-02, Vol.16 (3), p.140-146
Hauptverfasser: Zhang, Erlong, Zhang, Chao, Su, Yongping, Cheng, Tianmin, Shi, Chunmeng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 146
container_issue 3
container_start_page 140
container_title Drug discovery today
container_volume 16
creator Zhang, Erlong
Zhang, Chao
Su, Yongping
Cheng, Tianmin
Shi, Chunmeng
description The development of multifunctional agents that could be used for simultaneous tumor targeting, imaging and treatment is a major goal in cancer research and is expected to contribute significantly to the realization of personalized oncology. Mitochondria are involved in diverse physiological activities and confer vital roles in cancer development and progression. Increasing efforts are being made to develop cancer treatment strategies based on various mitochondrial targets and novel mitochondrial drug delivery systems. Multifunctional nanostructures or multifunctional chemical compounds further broaden the current concept of tumor targeting and provide alternative solutions for mitochondrially targeted cancer therapy.
doi_str_mv 10.1016/j.drudis.2010.12.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_851749970</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1359644610008445</els_id><sourcerecordid>851749970</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-7c6ca222291c686a5eca0c5b9ee25894912ced57baec9fef44fb624ee7f43e223</originalsourceid><addsrcrecordid>eNp9kEFvFCEYhonR2Fr9B8bMxfQ0KzDADBcT07TWpNFLPRrCfnxs2cwMKzA1--_LZtcey-UjX573hTyEfGR0xShTX7YrlxYX8orTw4qvKFWvyDkb-qGVQ8df13sndauEUGfkXc5bShnXUr0lZ5yxgeuBnZM_P_HfuG8cPuIYd-iaXJItuAmYGx9TMy1jCX6ZoYQ427GZQonwEGeXgm2LTRssNWQ3OJfchLkBOwOmpjxgsrv9e_LG2zHjh9O8IL9vru-vbtu7X99_XH27a6HTrLQ9KLC8Hs1ADcpKBEtBrjUil4MWmnFAJ_u1RdAevRB-rbhA7L3okPPuglwee3cp_l0wFzOFDDiOdsa4ZDNI1gute1pJcSQhxZwTerNLYbJpbxg1B69ma45ezcGrYdxUrzX26fTAsp7QPYf-i6zA5xNgM9jRp-qhdjxznaaUy0PR1yOHVcdjwGQyBKzOXEgIxbgYXv7JE5jrmsA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>851749970</pqid></control><display><type>article</type><title>Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Zhang, Erlong ; Zhang, Chao ; Su, Yongping ; Cheng, Tianmin ; Shi, Chunmeng</creator><creatorcontrib>Zhang, Erlong ; Zhang, Chao ; Su, Yongping ; Cheng, Tianmin ; Shi, Chunmeng</creatorcontrib><description>The development of multifunctional agents that could be used for simultaneous tumor targeting, imaging and treatment is a major goal in cancer research and is expected to contribute significantly to the realization of personalized oncology. Mitochondria are involved in diverse physiological activities and confer vital roles in cancer development and progression. Increasing efforts are being made to develop cancer treatment strategies based on various mitochondrial targets and novel mitochondrial drug delivery systems. Multifunctional nanostructures or multifunctional chemical compounds further broaden the current concept of tumor targeting and provide alternative solutions for mitochondrially targeted cancer therapy.</description><identifier>ISSN: 1359-6446</identifier><identifier>EISSN: 1878-5832</identifier><identifier>DOI: 10.1016/j.drudis.2010.12.006</identifier><identifier>PMID: 21182981</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Animals ; Antineoplastic Agents - administration &amp; dosage ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - therapeutic use ; Biological and medical sciences ; Drug Delivery Systems ; Drug Discovery ; General pharmacology ; Humans ; Medical sciences ; Mitochondria - drug effects ; Mitochondria - metabolism ; Molecular Structure ; Neoplasms - drug therapy ; Neoplasms - metabolism ; Neoplasms - pathology ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments</subject><ispartof>Drug discovery today, 2011-02, Vol.16 (3), p.140-146</ispartof><rights>2010 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-7c6ca222291c686a5eca0c5b9ee25894912ced57baec9fef44fb624ee7f43e223</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1359644610008445$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23900256$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21182981$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Erlong</creatorcontrib><creatorcontrib>Zhang, Chao</creatorcontrib><creatorcontrib>Su, Yongping</creatorcontrib><creatorcontrib>Cheng, Tianmin</creatorcontrib><creatorcontrib>Shi, Chunmeng</creatorcontrib><title>Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy</title><title>Drug discovery today</title><addtitle>Drug Discov Today</addtitle><description>The development of multifunctional agents that could be used for simultaneous tumor targeting, imaging and treatment is a major goal in cancer research and is expected to contribute significantly to the realization of personalized oncology. Mitochondria are involved in diverse physiological activities and confer vital roles in cancer development and progression. Increasing efforts are being made to develop cancer treatment strategies based on various mitochondrial targets and novel mitochondrial drug delivery systems. Multifunctional nanostructures or multifunctional chemical compounds further broaden the current concept of tumor targeting and provide alternative solutions for mitochondrially targeted cancer therapy.</description><subject>Animals</subject><subject>Antineoplastic Agents - administration &amp; dosage</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Drug Delivery Systems</subject><subject>Drug Discovery</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - metabolism</subject><subject>Molecular Structure</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><issn>1359-6446</issn><issn>1878-5832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEFvFCEYhonR2Fr9B8bMxfQ0KzDADBcT07TWpNFLPRrCfnxs2cwMKzA1--_LZtcey-UjX573hTyEfGR0xShTX7YrlxYX8orTw4qvKFWvyDkb-qGVQ8df13sndauEUGfkXc5bShnXUr0lZ5yxgeuBnZM_P_HfuG8cPuIYd-iaXJItuAmYGx9TMy1jCX6ZoYQ427GZQonwEGeXgm2LTRssNWQ3OJfchLkBOwOmpjxgsrv9e_LG2zHjh9O8IL9vru-vbtu7X99_XH27a6HTrLQ9KLC8Hs1ADcpKBEtBrjUil4MWmnFAJ_u1RdAevRB-rbhA7L3okPPuglwee3cp_l0wFzOFDDiOdsa4ZDNI1gute1pJcSQhxZwTerNLYbJpbxg1B69ma45ezcGrYdxUrzX26fTAsp7QPYf-i6zA5xNgM9jRp-qhdjxznaaUy0PR1yOHVcdjwGQyBKzOXEgIxbgYXv7JE5jrmsA</recordid><startdate>20110201</startdate><enddate>20110201</enddate><creator>Zhang, Erlong</creator><creator>Zhang, Chao</creator><creator>Su, Yongping</creator><creator>Cheng, Tianmin</creator><creator>Shi, Chunmeng</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110201</creationdate><title>Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy</title><author>Zhang, Erlong ; Zhang, Chao ; Su, Yongping ; Cheng, Tianmin ; Shi, Chunmeng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-7c6ca222291c686a5eca0c5b9ee25894912ced57baec9fef44fb624ee7f43e223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - administration &amp; dosage</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Drug Delivery Systems</topic><topic>Drug Discovery</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - metabolism</topic><topic>Molecular Structure</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Erlong</creatorcontrib><creatorcontrib>Zhang, Chao</creatorcontrib><creatorcontrib>Su, Yongping</creatorcontrib><creatorcontrib>Cheng, Tianmin</creatorcontrib><creatorcontrib>Shi, Chunmeng</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Drug discovery today</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Erlong</au><au>Zhang, Chao</au><au>Su, Yongping</au><au>Cheng, Tianmin</au><au>Shi, Chunmeng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy</atitle><jtitle>Drug discovery today</jtitle><addtitle>Drug Discov Today</addtitle><date>2011-02-01</date><risdate>2011</risdate><volume>16</volume><issue>3</issue><spage>140</spage><epage>146</epage><pages>140-146</pages><issn>1359-6446</issn><eissn>1878-5832</eissn><abstract>The development of multifunctional agents that could be used for simultaneous tumor targeting, imaging and treatment is a major goal in cancer research and is expected to contribute significantly to the realization of personalized oncology. Mitochondria are involved in diverse physiological activities and confer vital roles in cancer development and progression. Increasing efforts are being made to develop cancer treatment strategies based on various mitochondrial targets and novel mitochondrial drug delivery systems. Multifunctional nanostructures or multifunctional chemical compounds further broaden the current concept of tumor targeting and provide alternative solutions for mitochondrially targeted cancer therapy.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>21182981</pmid><doi>10.1016/j.drudis.2010.12.006</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1359-6446
ispartof Drug discovery today, 2011-02, Vol.16 (3), p.140-146
issn 1359-6446
1878-5832
language eng
recordid cdi_proquest_miscellaneous_851749970
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - chemistry
Antineoplastic Agents - therapeutic use
Biological and medical sciences
Drug Delivery Systems
Drug Discovery
General pharmacology
Humans
Medical sciences
Mitochondria - drug effects
Mitochondria - metabolism
Molecular Structure
Neoplasms - drug therapy
Neoplasms - metabolism
Neoplasms - pathology
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
title Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T15%3A14%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Newly%20developed%20strategies%20for%20multifunctional%20mitochondria-targeted%20agents%20in%20cancer%20therapy&rft.jtitle=Drug%20discovery%20today&rft.au=Zhang,%20Erlong&rft.date=2011-02-01&rft.volume=16&rft.issue=3&rft.spage=140&rft.epage=146&rft.pages=140-146&rft.issn=1359-6446&rft.eissn=1878-5832&rft_id=info:doi/10.1016/j.drudis.2010.12.006&rft_dat=%3Cproquest_cross%3E851749970%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=851749970&rft_id=info:pmid/21182981&rft_els_id=S1359644610008445&rfr_iscdi=true